Trade Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for potential clinical benefit in multiple therapeutic areas. The most advanced clinical programs in the company's investigations are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in the evaluation of inflammatory indicators and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company converted it and shifted its focus to the development of new drugs currently being tested in clinical trials. Arena Pharmaceuticals Is a biopharmaceutical company founded in 1997 and located in San Diego, California. Arena focused on the discovery of drugs that work on the associated G-protein receptors (GPCRs). The company has developed a technology called Activative Receptor Technology (CART) that identified the drug leading targeting GPCRs and other receptor classes. CART has been used to identify leading drugs capable of serving as receptor inhibitors to reduce biological response or act as receptor steroids to increase biological response.